These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
464 related articles for article (PubMed ID: 26235450)
21. Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study. Oldgren J; Åsberg S; Hijazi Z; Wester P; Bertilsson M; Norrving B; Circulation; 2022 Oct; 146(14):1056-1066. PubMed ID: 36065821 [TBL] [Abstract][Full Text] [Related]
22. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation. Grosset-Janin D; Barth E; Bertrand B; Detante O Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470 [TBL] [Abstract][Full Text] [Related]
23. Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial. Åsberg S; Hijazi Z; Norrving B; Terént A; Öhagen P; Oldgren J Trials; 2017 Dec; 18(1):581. PubMed ID: 29197413 [TBL] [Abstract][Full Text] [Related]
24. Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial. Shoamanesh A; Hart RG; Connolly SJ; Kasner SE; Smith EE; Martí-Fàbregas J; Liu YY; Uchiyama S; Mikulik R; Veltkamp R; O'Donnell MJ; Ntaios G; Muir KW; Field TS; Santo GC; Olavarria V; Mundl H; Lutsep H; Berkowitz SD; Sharma M JAMA Neurol; 2021 Jan; 78(1):11-20. PubMed ID: 33074284 [TBL] [Abstract][Full Text] [Related]
25. Non-vitamin K oral anticoagulants as first-line regimen for acute ischemic stroke with non-valvular atrial fibrillation. Park CW; Nam HS; Heo JH; Park HJ; Choi JK; Lee HS; Na HK; Kim YD J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105025. PubMed ID: 32807440 [TBL] [Abstract][Full Text] [Related]
26. Fatal intracranial haemorrhage occurring after oral anticoagulant treatment initiation for secondary stroke prevention in patients with atrial fibrillation. Tsivgoulis G; Katsanos AH; Seiffge DJ; Paciaroni M; Wilson D; Koga M; Macha K; Cappellari M; Kallmünzer B; Polymeris AA; Toyoda K; Caso V; Werring DJ; Engelter ST; De Marchis GM; Eur J Neurol; 2020 Aug; 27(8):1612-1617. PubMed ID: 32333493 [TBL] [Abstract][Full Text] [Related]
27. Ischemic stroke and non-valvular atrial fibrillation: When to introduce anticoagulant therapy? Boursier-Bossy V; Zuber M; Emmerich J J Med Vasc; 2020 Apr; 45(2):72-80. PubMed ID: 32265018 [TBL] [Abstract][Full Text] [Related]
28. Cerebral microbleeds as a risk factor for subsequent intracerebral hemorrhages among patients with acute ischemic stroke. Fan YH; Zhang L; Lam WW; Mok VC; Wong KS Stroke; 2003 Oct; 34(10):2459-62. PubMed ID: 12958325 [TBL] [Abstract][Full Text] [Related]
29. Long-Term Prognostic Implications of Cerebral Microbleeds in Chinese Patients With Ischemic Stroke. Lau KK; Wong YK; Teo KC; Chang RSK; Tse MY; Hoi CP; Chan CY; Chan OL; Cheung RHK; Wong EKM; Kwan JSK; Hui ES; Mak HKF J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29217662 [TBL] [Abstract][Full Text] [Related]
30. Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials. Ntaios G; Papavasileiou V; Diener HC; Makaritsis K; Michel P Int J Stroke; 2017 Aug; 12(6):589-596. PubMed ID: 28730948 [TBL] [Abstract][Full Text] [Related]
31. Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study. Paciaroni M; Caso V; Agnelli G; Mosconi MG; Giustozzi M; Seiffge DJ; Engelter ST; Lyrer P; Polymeris AA; Kriemler L; Zietz A; Putaala J; Strbian D; Tomppo L; Michel P; Strambo D; Salerno A; Remillard S; Buehrer M; Bavaud O; Vanacker P; Zuurbier S; Yperzeele L; Loos CMJ; Cappellari M; Emiliani A; Zedde M; Abdul-Rahim A; Dawson J; Cronshaw R; Schirinzi E; Del Sette M; Stretz C; Kala N; Reznik M; Schomer A; Grory BM; Jayaraman M; McTaggart R; Yaghi S; Furie KL; Masotti L; Grifoni E; Toni D; Risitano A; Falcou A; Petraglia L; Lotti EM; Padroni M; Pavolucci L; Lochner P; Silvestrelli G; Ciccone A; Alberti A; Venti M; Traballi L; Urbini C; Kargiotis O; Rocco A; Diomedi M; Marcheselli S; Caliandro P; Zauli A; Reale G; Antonenko K; Rota E; Tassinari T; Saia V; Palmerini F; Aridon P; Arnao V; Monaco S; Cottone S; Baldi A; D'Amore C; Ageno W; Pegoraro S; Ntaios G; Sagris D; Giannopoulos S; Kosmidou M; Ntais E; Romoli M; Pantoni L; Rosa S; Bertora P; Chiti A; Canavero I; Saggese CE; Plocco M; Giorli E; Palaiodimou L; Bakola E; Tsivgoulis G; Bandini F; Gasparro A; Terruso V; Mannino M; Pezzini A; Ornello R; Sacco S; Popovic N; Scoditti U; Genovese A; Denti L; Flomin Y; Mancuso M; Ferrari E; Caselli MC; Ulivi L; Giannini N; De Marchis GM Stroke; 2022 Aug; 53(8):2620-2627. PubMed ID: 35543133 [TBL] [Abstract][Full Text] [Related]
32. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage. Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848 [TBL] [Abstract][Full Text] [Related]
33. To Treat or Not to Treat: Anticoagulants as Secondary Preventives to the Oldest Old With Atrial Fibrillation. Appelros P; Farahmand B; Terént A; Åsberg S Stroke; 2017 Jun; 48(6):1617-1623. PubMed ID: 28487335 [TBL] [Abstract][Full Text] [Related]
34. Brain MRI microbleeds and risk of intracranial hemorrhage in atrial fibrillation patients: A Swedish case-control study. Aspberg S; Cheng D; von Heijne A; Gigante B; Singer DE J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107629. PubMed ID: 38325675 [TBL] [Abstract][Full Text] [Related]
35. Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study. Picard F; Ducrocq G; Danchin N; Falissard B; Hanon O; Mahe I; Touzé E; Steg PG Arch Cardiovasc Dis; 2018 May; 111(5):349-356. PubMed ID: 29191525 [TBL] [Abstract][Full Text] [Related]
36. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale. Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497 [TBL] [Abstract][Full Text] [Related]
37. Anticoagulation Protocol for Secondary Prevention of Acute Ischemic Stroke Associated with Nonvalvular Atrial Fibrillation. Kimura T; Tucker A; Nakagaki A; Sugimura T; Fukuda S; Katsuno M; Fujita T; Izumi N; Suzuki N; Sako K J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105893. PubMed ID: 34107414 [TBL] [Abstract][Full Text] [Related]